Dr. Sukanya Bhrugumalla-Gastroenterologist

Dr. Sukanya Bhrugumalla

MBBS, MD, DM (Gastro)

Gastroenterologist

Practice Location of Dr. Sukanya Bhrugumalla

Punjagutta Road, Punjagutta Market,

Panjagutta, Hyderabad

Get Directions
OP Timings

Mon - Sat

08:00 am - 11:00 am

Fee: 100

  • Practice Locations (1)

  • Profile

  • Patient Reviews

  • Q&A

Specializations

  • Gastroenterologist

Qualifications

  • MBBS
  • MD
  • DNB - Gastroenterology

Experiences

  • Consultant Gastroenterologist Nizams Institute of Medical Sciences - Panjagutta - Currently Working

Memberships

  • Indian Society of Gastroenterology
  • Indian Society for the Study of Liver Diseases

Paper Presentations

  • Co Investigator in Global Multicentre Phase II Trial - GI-5005 Therapeutic Vaccine Plus Peg - IFN/Ribavirin Improves End of Treatment Response at 48 Weeks Versus Peg - IFN/Ribavirin in Nave Genotype 1 Chronic HCV Patient 2008
  • Co Investigator in Global Multicentre Phase II Trial - An Evaluation of 2 Dose Routes of HDV Interferon (HDV-IFN) Administered with Ribavirin in the Treatment of Chronic Hepatitis C Non Responder and Naive Hepatitis C Patients 2008
  • Co Investigator in Global Multicentre Phase III Trial - Open Labeled, Randomised, Multicentre, Active-Controlled, Dose Ranging Study to Evaluate The Safety and Efficacy of Albinterferon Alfa-2b Administered Every 4 Weeks Plus Ribavirin in Interferon Alfa Naive Patients with Genotype 2/3 Chronic Hepatitis C 2009
  • Co Investigator in Global Multicentre Phase II Trial - Randomised, Double Blind, Placebo Controlled, Phase 2b Study to Assess the Safety and Efficacy Effects of Art -123 on Subjects with Sepsis and Dsseminated Intravascular Coagulation 2010
  • Principle Investigator in Nationwide Multicentre Phase III Trial - Single Dose Delayed Released Mesalamine in Moderately Active Ulcerative Colitis 2011
  • Co Investigator in Nationwide Multicentre Phase IV Trial - Open Label Study to Evaluate the Safety and Efficacy of Amphotericin B Lipid Suspension for Injection (Amfy) in Immunocompromised Patients with Invasive Fungal Infections (IFI) 2011
  • Co Investigator in THE APPROACH STUDY - Safety and Efficacy of Boceprevir in Combination with Peg Interferon Plus Ribavirin for Treatment of Asia Pacific Subjects with Chronic Hepatitis C Genotype 1 who Failed Prior Treatment with Pegylated Interforon Plus Ribavirin 2013

Report an error

Patient Reviews for Dr. Sukanya Bhrugumalla

No feedback

No feedback available for this Doctor.
Be the first to write a review.

Question & Answers by Dr. Sukanya Bhrugumalla

No Questions

No Question & Answers by this doctor.